{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
riboflavin phosphate
to a specific field?
Status:
US Approved Rx
(2021)
Source:
BLA761194
(2021)
Source URL:
First approved in 2021
Source:
BLA761194
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
BLA761047
(2017)
Source URL:
First approved in 2017
Source:
BLA761047
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2015)
Source:
BLA125513
(2015)
Source URL:
First approved in 2015
Source:
BLA125513
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:zeleciment basivarsen [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:delpacibart braxlosiran [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:delpacibart etedesiran [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
37-9.: Not Applicable Human clinical trial Completed N/A
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegtarviliase [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03428022: Phase 3 Interventional Unknown status NSCLC
(2017)
Source URL:
Class:
PROTEIN
